About
Kyntra Bio (formerly FibroGen) is a biopharmaceutical company developing therapies for serious and life-threatening diseases, focusing on oncology, anemia, and rare diseases through clinical pipeline drug development.
Explore Kyntra Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.